by Andrew Mahoney | Mar 17, 2023 | Blog
Last week the LaVoieHealthScience senior management team attended and supported our clients participating at the 43rd Annual TD Cowen Healthcare Conference in Boston – held in person for the first time in three years. Paul Sagan, VP, Investor Relations &...
by Andrew Mahoney | Jan 30, 2023 | Blog
JP Morgan Week wrapped up earlier this month with a flurry of new data, partnerships, investor meetings, and pharmaceutical interest. Here are the five key takeaways of the conference and what to expect as we come to the end the first month of the year: Biotech...
by Andrew Mahoney | Oct 26, 2022 | Blog
During these times of rapid change, it is increasingly important to strengthen one’s ability to adapt and communicate under pressure. Your company’s ability to communicate is the difference between success and failure, making it imperative that your company has the...
by Andrew Mahoney | Sep 22, 2022 | Blog
The return of in-person conferences coming back to Boston is great to see. The late Summer and early Fall have been busy with the very well-attended 42nd Canaccord Genuity Growth Conference in August, along with Citi’s 19th Annual BioPharma and Wells Fargo’s 2022...
by Andrew Mahoney | Jul 5, 2022 | Blog
by Gemma Bakx, SVP, Investor Relations and ESG GB: Donna, you have been presenting How to Tell Your Company Story in 15 Slides at the Biotechnology Innovation Organization International Convention for many years. What is your history with BIO, and what are the...
by Andrew Mahoney | Jun 21, 2022 | Blog
An Interview with Gemma Bakx, head of Investor Relations and ESG at LaVoieHealthScience by Paul Sagan, VP, Investor Relations and Corporate Communications PS: What led to your investor relations role at LHS? GB: Donna Lavoie founded her integrated communications...
Recent Comments